NexGard Spectra for Dogs 8.1-16 lbs (3.6-7.5 kg)

NexGard Spectra for Dogs 8.1-16 lbs (3.6-7.5 kg)

Nexgard Spectra Chewable Tablets for Dogs 8.1-16 lbs (3.6-7.5 kg) is a comprehensive, all-in-one chewable treatment designed to protect small to medium-sized dogs from a wide range of parasites. This beef-flavored chewable is easy to administer, ensuring stress-free monthly treatments that dogs love. NexGard Spectra combines two active ingredients, Afoxolaner and Milbemycin Oxime, to provide broad-spectrum protection against fleas, ticks, heartworms, and intestinal worms.

Indications

NexGard Spectra is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations, including black-legged tick (Ixodes scapularis), American dog tick (Dermacentor variabilis), Lone star tick (Amblyomma americanum), and brown dog tick (Rhipicephalus sanguineus). It also prevents heartworm disease caused by Dirofilaria immitis and treats and controls adult hookworm (Ancylostoma caninum), roundworm (Toxocara canis), and whipworm (Trichuris vulpis) infections. This product is suitable for dogs 8 weeks of age and older, weighing 8.1-16 lbs (3.6-7.5 kg).

Possible Side Effects

The most commonly reported side effects of NexGard Spectra include vomiting, itching, diarrhea, lethargy, and lack of appetite. In rare cases, neurological signs such as tremors, ataxia, and seizures have been reported. Use NexGard Spectra with caution in dogs with a history of seizures or neurological disorders.

Precautions

Afoxolaner and Milbemycin Oxime, the active ingredients in NexGard Spectra, belong to classes of drugs that have been associated with neurologic adverse reactions such as tremors, ataxia, and seizures. Use NexGard Spectra with caution in dogs with a history of neurologic disorders. This product has not been proven effective for puppies less than 8 weeks of age.

NexGard Spectra Protective Measures

• Not for Human Consumption: NexGard Spectra is intended for use in dogs only.
• Use with Caution: Use NexGard Spectra with caution in dogs with a history of neurologic disorders, as the active ingredients have been associated with neurologic adverse reactions.
• Consult Your Vet: Consult your veterinarian before using NexGard Spectra in breeding, pregnant, or lactating females.
• Storage and Handling: Keep the chewable tablet out of reach of pets and children. Do not open the package until required. Avoid eating, drinking, and smoking while administering the dosage. Wash hands with soap and water after handling the chewable.

Contraindications

NexGard Spectra is contraindicated for use in dogs with known hypersensitivity to Afoxolaner, Milbemycin Oxime, or any of the product’s components. Do not use NexGard Spectra in dogs that have shown adverse reactions to isoxazoline class drugs. NexGard Spectra is also contraindicated in puppies less than 8 weeks of age.